HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potential Pitfalls of a Fiducial Marker-matching Technique in Carbon-ion Radiotherapy for Lung Cancer.

AbstractBACKGROUND/AIM:
To analyze the accuracy of patient positioning and dose distribution quality using a fiducial marker-matching technique in carbon-ion radiotherapy (C-ion RT) for stage I lung cancer.
PATIENTS AND METHODS:
Thirteen patients with 26 fiducial markers and 104 radiation fields were examined. Change in the fiducial marker position coordinates from the gross tumor volume center (Δm), and change in the water-equivalent path length of the chest wall (ΔWEL) were measured in each radiation field. Criterion for an acceptable change in dose distribution was defined as the percentage of D95 (%D95) at gross tumor volume greater than 90% of the prescribed dose.
RESULTS:
Thirteen radiation fields (12.5%) were classified as unacceptable. Δm and ΔWEL had significant negative correlations with %D95 and thus were significant factors related to unacceptable irradiation fields.
CONCLUSION:
Patient positioning using a fiducial marker-matching technique resulted in 12.5% of radiation fields demonstrating unacceptable degradation due to Δm and ΔWEL.
AuthorsShintaro Shiba, Jun-Ichi Saitoh, Daisuke Irie, Katsuyuki Shirai, Takanori Abe, Yoshiki Kubota, Makoto Sakai, Ryosuke Okada, Tatsuya Ohno, Takashi Nakano
JournalAnticancer research (Anticancer Res) Vol. 37 Issue 10 Pg. 5673-5680 (10 2017) ISSN: 1791-7530 [Electronic] Greece
PMID28982885 (Publication Type: Journal Article)
CopyrightCopyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Topics
  • Area Under Curve
  • Carcinoma, Non-Small-Cell Lung (diagnostic imaging, pathology, radiotherapy)
  • Fiducial Markers
  • Heavy Ion Radiotherapy (adverse effects, instrumentation, methods)
  • Humans
  • Lung Neoplasms (diagnostic imaging, pathology, radiotherapy)
  • Neoplasm Staging
  • Patient Positioning (adverse effects)
  • Predictive Value of Tests
  • ROC Curve
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted
  • Retrospective Studies
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tumor Burden

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: